Cogent Biosciences, Inc. (COGT)
38.89
+0.04
(+0.10%)
USD |
NASDAQ |
Mar 02, 16:00
38.16
-0.73
(-1.88%)
Pre-Market: 08:08
Cogent Biosciences Shareholders Equity (Quarterly) : 636.37M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Sarepta Therapeutics, Inc. | 1.141B |
| BridgeBio Pharma, Inc. | -2.087B |
| Olema Pharmaceuticals, Inc. | 307.49M |
| Revolution Medicines, Inc. | 1.631B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.61M |
| Total Liabilities (Quarterly) | 301.24M |
| Debt to Equity Ratio | 0.3752 |
| Current Ratio | 14.23 |
| Net Debt Paydown Yield | -0.77% |